CD19-directed CAR-T cell therapy
/ University of Sao Paulo
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 23, 2026
CLEVER-SLE: CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus
(clinicaltrials.gov)
- P1/2 | N=16 | Not yet recruiting | Sponsor: University of Sao Paulo
IO biomarker • New P1/2 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
December 09, 2024
CARTHEDRALL: CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
(clinicaltrials.gov)
- P1/2 | N=81 | Recruiting | Sponsor: University of Sao Paulo | Not yet recruiting ➔ Recruiting
CAR T-Cell Therapy • Enrollment open • Acute Lymphocytic Leukemia • B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • BCL2
October 26, 2023
CARTHEDRALL: CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
(clinicaltrials.gov)
- P1/2 | N=81 | Not yet recruiting | Sponsor: University of Sao Paulo
CAR T-Cell Therapy • New P1/2 trial • Acute Lymphocytic Leukemia • Follicular Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • BCL2
1 to 3
Of
3
Go to page
1